ClinicalTrials.gg
Sign In

Drug

N-acetylmannosamine clinical trials

Also written ManNAc.

studies test it
5
open now
1
in phase 3
0
first study started
2012

Keep track of what changes. Save the N-acetylmannosamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Other names

ManNAc
4

Studies by the year they started

5 studies that test it; most in 2012 (1)

Studies that test N-acetylmannosamine, by start year
YearStudies
20121
20151
20161
20221
20261

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
3

What it is tested for

Each study’s main condition, where its own words name it.

Muscular Diseases
2
Kidney Diseases
1
Glomerulosclerosis, Focal Segmental
1

Who runs them

Industry 1 · Other 4

National Human Genome Research Institute (NHGRI) (3) · Leadiant Biosciences, Inc. (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)

Studies

Open first, then newest update. How each study uses N-acetylmannosamine is read from its arms, and is right about nine times in ten.

Testing it · 5

Codes

What other systems call N-acetylmannosamine · ClinicalTrials.gg INT002244

  • MeSH (NLM) C002022N-acetylmannosamineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) X80PR7P73RN-ACETYLMANNOSAMINEConfirmed NLM, Wikidata
  • Wikidata Q27293654N-acetylmannosamineConfirmed NLM, Wikidata
  • DrugBank DB12536One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.